Mark is an asset to our team who is passionate about our mission to help patients treat cardiometabolic diseases through behavioral change.
After starting with our team in January to assist with the financing process and audit in preparation of the SPAC merger, he officially joined us full-time in May to help steer and grow our finance team. He brings extensive experience working in finance leadership and a successful track record of building strong, cohesive teams and executing business plans that drive revenue growth and company profitability. We are lucky to have his experience and passion on our team!
What attracted you to Better Therapeutics?
I was drawn to Better because it has a vision to help people. I am also a firm believer in improving health through lifestyle changes such as diet and exercise.
What do you find most exciting about the type of work you do?
I am excited by the challenge. It started with getting Better through its first audit. Now I am building a new team and am excited to teach and mentor them.
What are you most looking forward to in your new role at Better Therapeutics?
I look forward to being part of building a great company. There are so many things to do as Better enters this period of rapid growth, and I am excited to be part of it.
Where do you find inspiration and purpose?
My wife and children. My wife was in finance prior to staying home to raise and educate our children (which frankly is a much harder job than finance). She also is my ‘executive coach’ helping me grow personally and professionally.
What is Mark Heinen's net worth?
The estimated net worth of Mark Heinen is at least $0.00 as of June 6th, 2024. Mr. Heinen owns 8,500 shares of Better Therapeutics stock worth more than $0 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Heinen may own. Learn More about Mark Heinen's net worth.
How do I contact Mark Heinen?
Has Mark Heinen been buying or selling shares of Better Therapeutics?
Mark Heinen has not been actively trading shares of Better Therapeutics over the course of the past ninety days. Most recently, on Monday, September 12th, Mark Heinen bought 23,868 shares of Better Therapeutics stock. The stock was acquired at an average cost of $1.94 per share, with a total value of $46,303.92. Following the completion of the transaction, the insider now directly owns 43,868 shares of the company's stock, valued at $85,103.92. Learn More on Mark Heinen's trading history.
Who are Better Therapeutics' active insiders?
